The body is fully adapted to the medication
However, the ability of cells to synthesize glutathione declines in certain disease states as well as part of ageing, probably due to lower levels of glutathione reductase enzyme
In December 2024, Eli Lilly, the US pharmaceutical giant, announced the launch of its blockbuster drug, Tirzepatide, in India in 2025
Screening for eating disorders is also recommended before initiating pharmacotherapy
The rationale for combining them is based on the hypothesis that parallel modulation of nitric oxide signaling, cytoskeletal dynamics, extracellular matrix remodeling, and oxidative stress responses may generate additive or synergistic effects in controlled experimental models
The argument is that this will deliver higher levels directly into muscles or bloodstream and makes the treatment more efficient than oral supplements